Do More With Reuters
Partner Services

Quote For Lupin Limited

Lupin Limited (LUPN.BO) (Bombay Stock Exchange)
sector: Healthcare · industry: Pharmaceuticals - Generic & Specialty ·
As of  24 Nov 2009
1,332.90INR
Price Change
+0.80
Percent Change
+0.06%
 
Research a stock:   symbol lookup
Rs1,332.90
24 Nov 2009
+0.06%
Rs1,332.10
Rs1,339.85
11,929
Rs1,370.00
Rs1,327.00
Rs1,380.00
Rs525.00
0.51
13,538

 

News

Key Developments

Officers

Name Current Position Compensation
Gupta, Desh Chairman of the Board 66,720,000
Gupta, Nilesh Group President, Executive Director --
Gupta, Vinita Group President & CEO of Lupin Pharmaceuticals Inc., USA, Non-Executive Director --

Key Ratios and Statistics

Share Related Items
Market Cap (Mil.) Rs114,788.60
Shares Outstanding (Mil.) 86.17
Float (Mil.) 44.20
Dividend Information
Yield % --
Annual Dividend (Rs INR) 12.50
Payout Ratio(TTM) % 18.03
Financial Strength
Quick Ratio 1.04
Current Ratio --
LT Debt/Equity --
Total Debt/Equity --
Valuation Ratios
Price/Earnings(TTM) 19.66
Price/Sales(TTM) 2.65
Price/Book(TTM) --
Price/Cash Flow(TTM) 16.75
Per Share Data
Earnings(TTM) Rs68.68
Sales(TTM) Rs511.08
Book Value(MRQ) Rs--
Cash Flow(TTM) Rs80.91
Cash(MRQ) Rs--
Management Effectiveness
Return on Equity(TTM) --
Return on Assets(TTM) --
Return on Investment(TTM) --
Margins
Gross Margin(TTM) % 29.25
Operating Margin(TTM) % 15.74
Profit Margin(TTM) % 13.62

Commodities

Commodity Last Pct Chg Trade Date/Time
Oil 76.57 +0.14% 11/25 08:39 IST
Gold 1173.6 +0.66% 11/25 08:22 IST